breast cancer - The U
normal (left) versus cancerous (right) mammography image. The U.S. National Cancer Institute recommends screening mammography every one to two years beginning at age 40. In the UK, women are invited for screening once every three years beginning at age 50. Women with one or more first-degree relatives (mother, sister, daughter) with premenopausal breast cancer should begin screening at one earlier age. It is usually suggested to start screening at an age that is 10 years less than the age at which the relative was , which is determined with breast cancer . A clinical practice guideline by the US Preventive Services Task Force recommended "screening mammography, with or without clinical breast examination (CBE), every 1 to 2 years for women aged 40 and older."
other good-like chest combines good-like breast tumors such as s or intraductal papillomas are abnormal growths, but they are not cancer and cannot spread outside of the breast to other organs. They are not life threatening. Still, some benign breast conditions are important because women with these conditions have a higher risk expanding breast cancer . For more information see the section, " What Are the Risk factors for breast cancer ?" and the American Cancer Society document, Noncancerous Breast Conditions . breast cancer general print-outs, which are it the important to understand some of the key words used , into of breast cancer . This is a term used to describe a cancer that begins in the lining layer (epithelial cells) of organs such as the breast. to describe almost everything breast cancer s of cancer ulcers (either ductal carcinomas or lobular carcinomas). An adenocarcinoma is a type of carcinoma that starts in glandular tissue (tissue that makes and secretes a substance). The ducts and lobules of the breast are glandular tissue (they make breast milk), so cancers starting in these areas are sometimes called adenocarcinomas. Carcinoma In Situ This term is used for the early stage of cancer, when it is confined to the layer of cells where it began. in breast cancer is meant specifically, in international telecommunication union that cancer cells remain confined to ducts (ductal carcinoma in situ) or lobules (lobular carcinoma in situ). They have not invaded into deeper tissues in the breast or spread to other organs in the body, and are sometimes referred to as nichtinvasives breast cancer s. Invasive (Infiltrating) Carcinoma An invasive cancer is one that has already invaded beyond the layer of cells where it started (as opposed to carcinoma in situ ). most breast cancer s invasive cancer ulcers are -- either invasive ductal carcinoma or invasive lobular carcinoma. Sarcomas are cancers that start from connective tissues such as fat tissue or blood vessels. Sarcomas of the breast are rare. types of breast cancer s are some types there of breast cancer , although some from them quite rare. It is not unusual for a single breast tumor to be a combination of these types and to have a mixture of invasive and in situ are
other dangers cover its overloaded, using hormone replacement therapy, taking birth control pills, drinking alcohol, not having children or having your first child after age 35 or having dense breasts. sign of breast cancer can a clot in the breast, a change in size or shape of the breast or discharge from a nipple. Breast self-exam and can help discovery breast cancer early contain, when it can have most treatable. Treatment may consist of radiation, lumpectomy, , chemotherapy and hormone therapy. breast cancer also is however the number cases is small. National Cancer Institute breast cancer (Patient Education Institute) - Requires Flash Player Also , which is available in breast cancer (PDQ): Treatment (National Cancer Institute) Also available in What You Need to , approximately to know startinghere breast cancer
paget disease is almost always associated with either ductal carcinoma in situ (DCIS) or, more often, with infiltrating ductal carcinoma. If no lump can be felt in the breast tissue and the biopsy shows DCIS but no invasive cancer, the prognosis is excellent. Tubular carcinoma: Tubular carcinomas are another special type of invasive ductal breast carcinoma. It was named tubular because of the way the cells look under the microscope. Tubular carcinomas account for about 2% everything breast cancer s and bends to have a better prognosis than infiltrating ductal or lobular carcinomas. Papillary carcinoma: The cells of these cancers tend to be arranged in small, finger-like projections when viewed under the microscope. These cancers are most often considered to be a subtype of ductal carcinoma in situ (DCIS), and are treated as such. In rare cases they are invasive, in which case they are treated like invasive ductal carcinoma, although the outlook is likely to be better. These cancers make up no more than 1% or 2% everything breast cancer s and they are inclined to be diagnosed in older women. Adenoid cystic carcinoma (adenocystic carcinoma): These cancers are so named because they have both glandular (adenoid) and cylinder-like (cystic) features when viewed under the microscope. They make up less than 1% of breast cancer s. They rarely spread to the lymph nodes or distant areas, and they tend to have a very good prognosis. Phyllodes tumor: This very rare breast tumor develops in the stroma (connective tissue) of the breast, in contrast to carcinomas, which develop in the ducts or lobules. Other names for , which these tumors contain
the part of the difficulty in interpreting mammograms in younger women stems from the problem of breast density. Radiographically, a dense breast has a preponderance of glandular tissue, and younger age or hormone replacement therapy contribute to mammographic breast density. After menopause, the breast glandular tissue gradually is replaced by fatty tissue, making mammographic interpretation much more accurate. Some authors speculate that part of the contribution of hormone replacement the therapy to breast cancer the number of deaths results from that expense of increased mammographic breast density. Breast density is an independent adverse prognostic factor on breast cancer prognosis . A systematic review by the American College of Physicians concluded "Although few women 50 years of age or older have risks from mammography that outweigh the benefits, the evidence suggests that more women 40 to 49 years of age have such risks". A report released November 27, 2007 by the Journal of the National Cancer Institute showed that the formula doctors use to calculate a woman's danger of breast cancer underestimates the danger, thus black detects women most of the time and especially for those age 50 and older the age when they are most likely to benefit from screening tests and protective drugs, according to the first major reassessment of the widely used tool. Enhancements to mammography In general, digital mammography and computer-aided mammography have increased the sensitivity of mammograms, but at the cost of more numerous false positive results. citation needed ] Computer-aided diagnosis (CAD) Systems may help radiologists to evaluate X-ray images breast cancer in initial stage . citation needed ] CAD is especially established in US and the Netherlands. It is used in addition to the human evaluation of the diagnostician. Breast MRI a magnetic resonance representation
their health protect - Prescribed DES While Pregnant (Centers for Disease Control and Prevention) Return to top Alternative Therapy Complementary Medicine (Breastcancer.org) Return to top food and breast cancer (Breastcancer.org) Return to top Emotional aspects breast cancer (Cleveland Clinic Foundation) For Women Facing a Breast Biopsy (American Cancer Society) When the Woman You of the love breast cancer ( y-me national breast cancer classification has mrs. ) - Large PDF file Also available in Return to top Disease Management What Happens After processing for the inflammatory breast cancer ? (American Cancer Society) Return to top Specific Conditions DCIS - Ductal Carcinoma In Situ (Breastcancer.org) her2-positive breast cancer (Mayo Foundation for Medical Education and Research) breast cancer